How to Choose a Private-Label Peptide Manufacturer: A 10-Point Checklist for Brands
Private label is where most consumer peptide brands win or lose on quality. The first run is the easy part. The relationship gets tested on the third re-order, the first packaging change, and the first quality question from a retailer’s QA team. Here is the diligence checklist before you sign the MSA.
Founders launching a private-label peptide brand spend a lot of time on the front of the funnel: brand identity, packaging, paid media, retailer pitch decks. They spend almost no time on the back of the funnel: the manufacturing partner who is going to decide, in practice, whether the brand has a 24-month story or a 6-month one.
The brands that survive are the ones that did the manufacturing diligence before they signed. Here is the checklist.
1. cGMP-aligned manufacturing — verifiable, not just claimed
Every supplier in this market says “cGMP.” The question is whether they can show you the documentation that backs the claim. Ask for the facility credential summary, the quality-system overview, and a redacted batch record. A supplier that can’t produce these in a week is not a supplier you should be putting your brand on.
Read more on what cGMP actually requires in our breakdown of cGMP peptide manufacturing.
2. HPLC purity testing on every production lot
HPLC purity is the line item on the COA that a serious QA reviewer looks at first. The bar in 2026 for clinical-grade peptide raw material is 99% or better; consumer-channel material runs in a similar band. Ask the manufacturer for sample COAs from recent production lots. If the purity number floats by more than 2–3 points across lots, the process is not in control.
3. Per-lot Certificate of Analysis — standard, not on request
The COA should ship with the order. Not on request, not for an extra fee, not in batches every quarter. If the manufacturer treats the COA as an exception document instead of a standard deliverable, you will spend the next two years chasing paperwork every time a retailer asks for it. See how to read a peptide Certificate of Analysis for what should be on it.
4. Lot traceability and chain-of-custody documentation
Every finished unit should be traceable to a manufacturing lot, and every manufacturing lot should be traceable to its raw material source. If a recall event happens (it eventually happens to every brand in this category), the difference between a 2-day investigation and a 2-week one is whether the manufacturer’s traceability system is real.
5. Endotoxin testing where applicable
For any injectable or parenteral peptide product, endotoxin testing is non-negotiable. Read the endotoxin testing plain-English guide for what good thresholds look like. A supplier that hand-waves on endotoxin is a supplier you should not work with on injectable SKUs, full stop.
6. Predictable lead time on re-orders
The first run is always pitched optimistically. Ask about the third and fourth re-order. What is the actual ship-from-PO time on a cataloged SKU? What is the on-time-in-full rate over the last 12 months? Suppliers that can’t answer these have not built the operational discipline you need.
7. Packaging configuration and tamper-evidence
Standard packaging is fine for some brands; custom packaging is necessary for others. Either way, the manufacturer should be able to handle tamper-evident seals, lot-coded labels, and packaging that survives a real fulfillment process. If they outsource packaging to a third party, ask who, and ask whether the lot-control story holds across the seam.
8. MOQ that fits a real launch
The right MOQ for a first run is usually 500–1,000 units per SKU. Suppliers that demand 5,000-unit minimums on a first run are optimizing for their production schedule, not for your launch curve. Suppliers that take 50-unit pilots are usually too small to scale with you. Find the middle.
9. A real conversation about regulatory lane
This is the biggest filter. A serious manufacturer will ask you which regulatory lane your product is in (supplement, prescription, partner-pharmacy, research) before they quote anything. A manufacturer who quotes without asking is a manufacturer who is going to drop you the moment a regulator looks at the channel sideways.
10. A named account contact, not a ticket queue
The single biggest operational difference between a good manufacturing partner and a mediocre one is whether you have a person whose phone you can call when something goes sideways at 4pm on a Friday. If onboarding hands you off to a ticket queue, expect to be in that queue for the rest of the relationship.